New studies identify advances in treatment of chronic myeloid leukemia
...ents whose disease is resistant to imatinib. Both dasatinib and AMN107 have been shown to be effective in trea... M. D. Anderson Cancer Center looked at the use of dasatinib in imatinib-resistant or intolerant patients with CML in late chronic phase (CP), accelerated phase ...5-year study shows Gleevec's potency against chronic myeloid leukemia
...ve testing of two other similar kinase inhibitors, dasatinib and nilotinib, now underway. "If dasatinib or nilotinib can beat Gleevec in the response they elicit, they will offer patients even greater pro...M. D. Anderson reports first drug activity in T315I-Positive CML, ALL and JAK-2-Positive MPD
...nce to imatinib (Gleevec), nilotinib (Tasigna) and dasatinib (Sprycel) in CML and ALL. These kinase inhibitors have been found to be effective treating patients with leukemias who carry different mutations. According to the study, the 35 leukemia patients on the study had at least four prior types of therapy...Dasatinib shows high early response rate as first treatment for chronic myelogenous leukemia
...s M. D. Anderson Cancer Center. "Patients taking dasatinib achieve complete cytogenetic response - absence of...L, which causes the disease. Atallah explains that dasatinib binds to both forms BCR-ABL while imatinib blocks only one. "Our hypothesis is that treating with ...